Foreign Drug Price Rule Nears Finish Line, to Publish Soon (1)

Nov. 20, 2020, 12:32 PMUpdated: Nov. 20, 2020, 7:05 PM

A Trump administration policy that ties U.S. reimbursement for certain expensive drugs to cheaper foreign prices is one step closer to taking effect after clearing White House review. It could be released at any time.

The action to match U.S. drugs to foreign drug prices cleared the Office of Management and Budget Thursday, the last step before it’s published in the Federal Register. It initially cleared White House review as a proposed rule, meaning it would not likely be finalized before President Donald Trump leaves office. The OMB has since changed it to an “interim final rule,” which means it ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.